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Abstract
Background: Primary ciliary dyskinesia (PCD) is rare. Its diagnosis requires experienced specialists and expensive 
infrastructure. Its prognosis is variable.  
Objective: To study the long-term outcome of  PCD in Tunisian children with ciliary ultra-structure defects detected 
by electron microscope.
Methods: Covering a period of  20 years (1996-2015), this retrospective study included all patients with definite PCD 
(outer dynein arms (DA) defects and/or situs inversus) and presumed PCD (other ciliary ultra-structure defects). The 
clinical data and the investigations made were registered at diagnosis and during the follow-up.
Results: Patients with a definite PCD (G1, n=7) were diagnosed earlier compared to those with a presumed PCD 
(G2, n=13) (2.5 vs. 9.3 years on average). At diagnosis, bronchiectasis was more frequent in G1 (3/7 vs. 4/13).  The 
inner DA loss was constant in G1 and predominant in G2. The treatment adhesion was more often irregular in G2 
(2/7 vs. 8/13). During a mean follow-up of  11 years, G1 showed less severe outcome (clubbing (0 vs. 3), bronchiec-
tasis (3 vs. 11; more expanded in G2), proximal and distal airway obstruction (0/3 vs. 5/7), lobectomy (0 vs. 2), and 
death (0 vs. 2)).
Conclusion: Precocious diagnosis and regular treatment may enhance the PCD prognosis.
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Introduction
Primary ciliary dyskinesia (PCD) is a rare inherited autoso-
mal-recessive disease. In Europe, the prevalence of  PCD 
is estimated at 1/10000. It is higher in certain regions, 
especially in North Africa probably because of  a high rate 
of  consanguinity1,2. PCD is caused by an abnormal struc-
ture and/or function of  the epithelial cell cilia and sperm 
tails. In the respiratory system, this anomalyimpairs mu-
cociliary clearance and leads to recurrent infections of  
the upper and lower airways in the first months of  life3. 
The PCD diagnosis requires an expensive infrastructure 
and an experienced team of  clinicians and scientists. In 
children, other chronic respiratory diseases, such as cystic 
fibrosis (CF), are often investigated before starting appro-
priate and complex PCD examination. The electron mi-
croscopic cilia study from a nasal or bronchial sample can 
detect the cilia defects, mainly in the dynein arms (DA) 
from the outer doublets, or a missing central pair asso-
ciated with a disarrangement of  the microtubules. The 
ciliary beat frequency can be assessed by a light microsco-
py and more recently by a high speed video-microscopy, 
available only in specialist centers across the globe1,4. The 
PCD medical treatment, based on daily airway clearance 
and antibiotics, is not standardized. It is usually extrapo-
lated from CF and non-CF bronchiectasis literature. The 
PCD monitoring should include regular sputum exam-
ination and lung function tests. The prognosis is variable. 
However, it is known to be better than the CF one5,6. 
In Tunisia, PCD is under-diagnosed. It needs a special-
ist physician to be recognized. The definitive diagnosis 
is difficult to establish. The unique tool to support PCD 
diagnosis at present is the electron microscope with a 
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limited availability. This microscope cannot detect all the 
PCD cases in Tunisia since patients with normal ciliary 
ultra-structure can have a genetically proven PCD7. On 
the other hand, for some ciliary abnormalities (an outer 
DA defect and a combined inner and outer DA defect), 
the PCD diagnosis is definitive. For others (an inner DA 
defect alone, or combined with a radial spoke defect), re-
peating the test to avoid the possibility of  a false-positive 
diagnosis is recommended8. This procedure cannot be 
fulfilled in our context given its cost. Because of  these 
obstacles, the specialist most often retains the PCD di-
agnosis only on clinical and radiological bases and after 
having excluded other major chronic respiratory diseases. 
In addition, confirming PCD diagnosis is not the only 
challenge. In fact, the management of  PCD in children 
requires a specialized paediatrician. The monitoring de-
pends closely on the availability of  access to medical 
health care. The aim of  this study was to assess the out-
come of  this rare disease in Tunisian children with detect-
ed ciliary ultra-structure defects.
Methods
Study design
This retrospective study was carried out in child and adult 
pulmonology referral units (Children’s Department B in 
Bechir Hamza Children’s Hospital of  Tunis and Depart-
ment C of  Abderrahman Mammi Hospital of  Ariana, re-
spectively) from 1996 to 2015. We collected all patients 
with a definitive diagnosis of  PCD based upon ciliary 
ultra-structure defects. In all cases, CF and immunodefi-
ciency were excluded by appropriate examinations (sweat 
test, immune investigation). The ciliary ultra-structure de-
fects were identified by an electron microscope cilia study, 
performed from nasal biopsy, ciliary brushing and/or 
bronchial biopsy. At least 100 ciliary cross-sections from 
healthy areas of  the respiratory epithelium per patient 
were analyzed. The PCD diagnosis was established when 
more than 40% of  the cilia were damaged. The patients 
regarded as affected with PCD because of  a compatible 
clinical and radiological phenotype without any ciliary ul-
tra-structure abnormalities or without an electron micro-
scopic cilia study were not included in this study.  
Two groups were determined. Group 1 corresponding 
to a definite PCD and included patients with outer DA 
defects and/or situs abnormalities. Group 2 related to a 
presumed PCD and included the patients with other cili-
ary ultra-structure defects and without situs inversus.
Data collection
Data was collected from patients’ medical records. For 
each patient, we noted the age at first symptoms and at 
diagnosis and the circumstances of  the PCD discovery. 
We registered the existence of  a family history of  PCD. 
We analysed the clinical data at diagnosis and during the 
monitoring as well as the results of  the different inves-
tigations made. The clinical data specified the presence 
of  recurrent or persistent upper and lower respiratory 
symptoms. The radiological exploration included a chest 
x-ray, x-ray of  the sinuses, chest CT scan, and echocardi-
ography. When a situs inversus was found on the chest 
x-ray, an abdominal ultrasound was performed to verify 
the mirror image arrangement of  the internal organs. The 
sputum culture was carried out at diagnosis, during an 
acute respiratory exacerbation and/or during the moni-
toring. The lung function tests were performed by pleth-
ysmography. They were based on the measurement of  
the specific airway resistance for the children aged more 
than four and on spirometry for those aged more than 
seven. The hearing acuity was assessed by audiometry 
during the monitoring. The management of  the disease 
was also analyzed. The minimal required duration of  the 
follow-up was one year.
Statistical analysis
This study was cross-sectional and descriptive. The data 
were entered using Excel software as qualitative and 
quantitative values. The variables were expressed as per-
centages and compared using the Chi square test. The 
Chi-square test associations were appropriate. The signif-
icance level of  “p” was 0.05.
Results
Twenty patients were registered as having PCD with cil-
iary ultra-structure defects. Group 1 (definite PCD) and 
group 2 (presumed PCD) included seven and 13 patients 
respectively. In group 1, the patients were divided into 
four boys and three girls. The average age at diagnosis 
was 2.5 years extremes: 3 months; 12 years. Four patients 
had a complete situs inversus relevant to Kartagener’ssyn-
drome. The diagnosis of  their PCD was earlier at the 
mean age of  6.5 months extremes: 3; 12 months (Table 
1). 
Parental consanguinity was found in four cases. The anal-
ysis of  the family history showed symptoms suggestive 
of  PCD (recurrent respiratory infections, infertility) in 
three cases. 
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The PCD was revealed by recurrent pneumonia in four 
cases, persistent wheezing in two cases, and chronic cough 
in one case. The neonatal respiratory distress was retro-
spectively found in three cases, always taken for a mater-
nal-fetal infection. At diagnosis, the physical examination 
showed wheezing (n=6) and crackles (n=4). In the ear, 
nose and throat (ENT) examination, three patients had 
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upper respiratory symptoms including purulent rhinitis, 
sinusitis and/or chronic otitis. One child aged 12 had na-
sal polyposis. The radiological abnormalities were mainly 
situs inversus (n=4) and lung distension (n=4) (Figure 1). 
The middle lobe was as much affected as the right up-
per lobe (n= 2 for each lobe). The patient aged 12 had 
normal lung function tests. The other patients hadn’t had 
these tests because of  their age.
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Compared to group 1, most patients from group 2 were 
older at diagnosis and the diagnosis delay was about three 
times longer (Table 1). Their clinical characteristics are 
illustrated in table 2. 
The dominant chest imaging abnormalities were lung 
distension and localized or diffuse alveolaro pacities 
(Figure 1). The middle lobe was affected in most of  the 
cases (n=10). The sinus radiography showed a unilateral 
(n=1/8) or bilateral maxillary sinusitis (n=7/8). The pul-
monary function tests showed airway obstruction in most 
cases (n=6/7) (Table 3).
Table 2: Clinical characteristics at diagnosis of group 2 
 
 Clinical features of group 2 Number of cases 
Gender : M / F 10 / 3 
Parental consanguinity 6 
Family history suggestive of primary ciliary dyskinesia 
Respiratory distress at birth 
2 
1 
Circumstances of PCD discovery: 
• recurrent lower respiratory infections 
• persistent wheezing 
• chronic cough 











• nasal polyposis 
• other upper respiratory symptoms (purulent rhinitis, 










The ultra-structural cilia study was performed from a 
nasal biopsy in seven cases, and a ciliary brushing and 
bronchial biopsy in 13 cases. The ciliary defect affected 
the majority of  the cell cilia in all cases. The main defect 
was the absence of  the inner DA (n=17). It was constant 
in group 1, and isolated in four cases in group 2 (Figure 
2 and 3).
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Table 3: Lung function test data at diagnosis of group 2 
  
Lung function tests data Number of patients Values 
•      Normal 1   
•      Proximal airway obstruction: 2   
•      Pre-/ Post β2-agonist sRaw % pred   180 - 160 / 152 - 120 
•      Pre-/ Post β2-agonist FEV1 % pred      69 – 67 / 71 – 77 
•      Distal airway obstruction: 3   
•      Pre-/ Post β2-agonist FEF25–75% % pred   24 - 38 - 44 /  33 - 45 – 48 
•      Major airway obstruction associated with a 
severe restrictive syndrome: 1   
•      Total vital capacity (% pred)   450 ml (22%) 
•      Pre-/ Post β2-agonist sRaw % pred              1020 / 805 
  
sRaw: specific airway resistance; FEV1: forced expiratory volume at one second; FEF25–
75%:forced expiratory flow between 25% and 75% of forced vital capacity; %pred: % of 
predicted value.   
In group 2, in the absence of  outer DA defects and situs 
inversus, the PCD diagnosis was retained given the clini-
cal data (consanguinity, family history of  infertility, and/
or association of  upper and lower chronic respiratory 
symptoms) and the investigation results (preferential in-
volvement of  the middle lobe on chest imaging, non-re-
versible airway obstruction on lung function tests, ciliary 
ultra-structure defects in the majority of  the cell cilia on 
the electron microscope, normal sweat test and immune 
investigation).
The washing of  nasal cavities, using isotonic saline, and 
chest physiotherapy were routinely recommended in all 
cases. The adhesion to physiotherapy was irregular in half  
the cases (group 1, n=2; group 2, n=8) owing to finan-
cial difficulties and the remoteness of  the physiotherapy 
centre. All patients received antibiotics during an acute 
respiratory tract infection. A rotating antibiotic therapy 
was indicated for eight children (group 1, n=4; group 2, 
n=4) in the cold season because of  their young age, a 
diffuse bronchiectasis, and/or difficult access to health-
care. It alternated the amoxicillin/clavulanic acid with 
the cotrimoxazole. Inhaled corticosteroids were added in 
half  the cases (group 1, n=2; group 2, n=8) because of  
frequent wheezing.  
The patients from group 1 had been monitored for 11 
years on average extremes: 5; 20. Five had regular clinical 
controls every three to six months and two consulted ir-
regularly because of  bad financial conditions. All of  them 
had normal growth and no limitation to any physical 
effort. In the absence of  a regular treatment (n=2), pa-
tients complained mainly of  chronic cough and nasal ob-
struction. For compliant patients (n=5), symptoms were 
more attenuated. Bronchiectasis secondarily appeared in 
three cases. It affected lower lobes as well as the mid-
dle lobe. After five years of  a regular monitoring, one 
case of  PCD, diagnosed at the age of  five months in a 
compliant patient, has not progressed to bronchiectasis. 
The respiratory infections occurred one to three times 
per year, managed as outpatients, and mainly caused by 
Haemophilus influenzae. The other isolated germs were 
Moraxella catarrhalis, Streptococcus pneumoniae, Hae-
mophilus parainfluenzae, andKlebsiella pneumoniae. No 
patient was affected with Pseudomonas aeruginosa. The 
follow-up of  the lung function tests, performed in three 
cases, showed lung inflation and a non-reversible decrease 
of  the distal airflow with forced expiratory flow between 
25% and 75% of  forced vital capacity (FEF25-75) less 
than 50% of  predicted value in all cases. 
In group 2, two patients had died of  acute respiratory 
distress syndrome (ARDS) after one and four years of  
follow up (respectively at the age of  13 and 6 (years)). 
The first one had a severe chronic respiratory failure at di-
agnosis associated with denutrition, wheezing, clubbing, 
oxygen dependency, diffuse bronchiectasis and a major 
airway obstruction associated with a severe restrictive 
syndrome on the lung function tests (Table 3). The sec-
ond had a complete ciliary agenesis at the microscopic 
study. He was eutrophic and had permanent wheezing 
despite a regular and optimal treatment. His chest CT-
scan showed important lung distension associated with 
bilateral bronchiectasis. No germ was found during the 
fatal respiratory infection in both cases.
The other 11 patients from group 2 had been monitored 
also for 11 years on average extremes: 5; 14. Those hav-
ing irregular physiotherapy (n=8) showed more severe 
exacerbations. A beginning of  clubbing was noticed in 
three cases. All patients from this group ended up with 
expanded bronchiectasis. During the respiratory exacer-
bations, the same bacteria found in group 1 were isolat-
ed. Two patients underwent resection of  the middle lobe, 
which was a frequent source of  suppuration. In addition 
to lung inflation and distal airflow decreasing, the lung 
function tests showed forced expiratory volume at one 
second (FEV1) less than 80% of  predicted value in five 
cases out of  seven.
For both groups, no persistent pulmonary hypertension 
was found in echocardiography monitoring. On the other 
hand, two patients (one from each group) had sensorineu-
ral deafness requiring hearing equipment and one patient 
from group 2 had a nasal polypectomy. Two patients(one 
from each group) developed mite induced allergic asthma 
at the age of  five and six contributing to in increasing 
respiratory exacerbations. The respiratory symptoms and 
the lung function tests improved after long-acting beta 
agonist inhaled corticosteroids were added.
 
Discussion
To our knowledge, this study is the first Tunisian pediat-
ric cohort grouping PCD cases confirmed by histological 
ciliary study although there are difficulties in ascertain-
ing the PCD diagnosis in our context. The cohort mainly 
highlighted the fact that despite an important diagnosis-
delay (4.8 years on average), the outcome of  this chronic 
disease over a mean period of  11 years extremes: 5; 20 
wasn’t severe in the majority of  cases. The 13-year-old 
child, who died one year after the PCD diagnosis, was 
in fact referred to us at an advanced stage of  the dis-
ease (chronic respiratory failure). Moreover, the cilia ul-
tra-structural abnormalities, detected by a sophisticated 
technique, allowed the distinction between two groups: 
definite PCD (group 1) and presumed PCD (group 2). 
The patients in group 1 were diagnosed earlier and had 
less severe outcome.  In group 2, a child with complete 
cilia agenesis was always wheezing and died at the age of  
six. However, the clinical and histological phenotype vari-
ations could not explain the outcome difference since the 
patients of  group 2 were less compliant. Because of  an 
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early diagnosis in group 1, the management of  the disease 
including parental education was precocious probably in-
fluencing the treatment compliance. In all cases, the PCD 
management remained dependent on the socio-economic 
status of  our patients and their ability to have access to 
healthcare. On the other hand, regular treatment made 
patients less symptomatic without stopping the progres-
sion of  the disease, especially for bronchiectasis.
Although the PCD symptoms appear usually early, its di-
agnosis is delayed with a mean age at diagnosis around 
five years in developed countries9-11. The presence of  a 
situs inversus allows precocious suspicion of  PCD12, as 
in four of  our patients. In fact, their PCD diagnosis was 
established at a mean age of  6.5 months whereas the av-
erage age at diagnosis of  all patients was 6.9 years. The 
diagnosis delay is explained by the non-specific respirato-
ry symptoms, first suggesting more frequent childhood 
conditions, and by the specialized PCD diagnostic tests 
available only in distinguished institutions. Indeed, most 
patients had several examinations (for example: sweat 
test, immune investigation, allergic tests) before the PCD 
diagnosis. The situs inversus is known to be present in 
around 50% of  PCD cases. It is one element of  the Kart-
agener’s syndrome triad. It is explained by a random dis-
tribution happening in the absence of  the leftward side 
flow induced by normal embryonic cilia rotation12,13. In 
our series, it was observed in 4/7 cases of  the definite 
PCD (group 1). Nevertheless, it was reported in 20% of  
all the cases because most physicians take for granted the 
diagnosis of  Kartagener’s syndrome in children with situs 
inversus and upper and lower respiratory infections with-
out making a transmission electronic microscopy study. 
These patients were not included in this study.  
The clinical feature of  the PCD is often homogeneous 
combining upper and lower respiratorymanifestations. 
The respiratory symptoms are present in 50-90% of  cases 
at birth consisting of  a transient tachypnea or ventilatory 
disorder14,15. Their favorable evolution delays the diagnos-
tic step. A recent case-control study identified in term ne-
onates with unexplained respiratory distress three factors 
to be considered by clinicians to better detect PCD: lobar 
collapse, situs inversus, and/or more than two day-long 
oxygen therapy16. In childhood, the chronic wet cough, 
persistent wheezing, recurrent pneumonia and bronchi-
ectasis lead to diagnosis when current explorations return 
negative. The ENT manifestations are early and can be in 
the foreground. In this study, half  the patients had per-
manent ENT symptoms at diagnosis, less than in the se-
ries of  Beucher et al9 and Sommer et al17 (86% and 81% 
respectively). The high prevalence of  the ENT morbidity 
in PCD should familiarize ENT specialists themselves 
with the disease to investigate patients in time.  
The measurement of  nasal nitric oxide (NO) is a good 
screening and non-invasive test in older children. The 
PCD is strongly suspected when the rate of  nasal NO is 
lowered18. This measure wasn’t available in our country 
during the study period. However, because it is not re-
liable in preschool children, this technique has a limited 
usefulness for early diagnosis.
The analysis of  ciliary ultra-structure using transmission 
electron microscopy leads to PCD confirmation in most 
of  the cases14. This method requires time, expansive 
equipment and experienced specialists for sampling and 
specimen analysis. The impairment of  DA was more fre-
quent than the absence of  the central pair in this study as 
well as in different series19,20.
The correspondence between genetic mutation and cy-
tological abnormalities was demonstrated, while the link 
between genetic analysis and clinical phenotype was more 
difficult to establish3,21,22.  A French retrospective study 
conducted among 60 children with PCD highlighted the 
relationship between the severity of  clinical presentation 
and the ultra-structural ciliary defect. The respiratory 
symptoms of  patients with DA loss occurred earlier and 
were less severe at diagnosis compared to patients with 
central pair abnormalities. The outcome was worse in 
the first group23. In this study, in group 1 which included 
the absence of  inner and outer DA, PCD was diagnosed 
earlier but the patients had more bronchiectasies at di-
agnosis than in group 2 which included the absence of  
central pair (3/7 vs. 4/13). The adherence to treatment 
influenced the PCD outcome in both groups. The PCD 
genetic analysis was implemented in our country in 2015. 
Its results are ongoing.
The PCD induces severe respiratory impairment but re-
mains accessible to medical treatment (chest physiother-
apy and antibiotics). The treatment must be early and 
regular. The ultimate solution for a completely destroyed 
and infected lobe is resection20. The Haemophilus influenzae 
is the most isolated germ during lung infections5,6, as in 
this study. It was confirmed also in a recent European 
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multicenter study enrolling 158 children with PDC. This 
pathogen was found at least once in 65% of  the patients. 
Pseudomonas aeruginosa was isolated in 58 patients (37%) 
of  whom eight (5%) were chronically infected. It wasn’t 
associated with spirometry changes unlike in CF24. No 
sputum culture showed this bacterium in our patients.
Maglione et al25 compared the change over time of  the 
lung structure in Chest CT-scan to the lung function 
in spirometry in 20 children with PCD. They conclud-
ed that CT scan scores deteriorated with age, while spi-
rometry did not change significantly, or might even have 
improved, suggesting that spirometry was less sensitive 
in assessing lung disease progression in PCD. Moreover, 
there was no correlation between the changes in CT scan 
scores and in spirometry.
Chronic rhinosinusitis significantly impacts children’s 
quality of  life in PCD. The surgery indications include 
nasal obstruction and polyposis. Endoscopic sinus sur-
gery and debridement of  sinonasal polyps are frequently 
performed with variable results26.
Conclusion
PCD remains under-recognized by physicians. A better 
awareness of  the clinical features of  the disease may help 
induce an early diagnosis and a precocious management. 
A regular treatment could help reduce disease morbidity.  
 
Limitations of  the study
It should be pointed out nevertheless that the limitations 
of  this study with regard to the diagnosis of  group 2 were 
imposed mainly by the absence of  a PCD genetics study 
and ciliary functional tests carried out by high-speed vid-
eo-microscopy in Tunisia.
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